{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:29:32Z","timestamp":1791646172272,"version":"4.3.4"},"reference-count":24,"publisher":"Japanese Circulation Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2019,1,25]]},"DOI":"10.1253\/circj.cj-18-0938","type":"journal-article","created":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T17:25:59Z","timestamp":1545845159000},"page":"441-446","source":"Crossref","is-referenced-by-count":19,"title":["Safety of Anticoagulant Therapy Including Direct Oral Anticoagulants in Patients With Acute Spontaneous Intracerebral Hemorrhage"],"prefix":"10.1253","volume":"83","author":[{"given":"Yuki","family":"Sakamoto","sequence":"first","affiliation":[{"name":"Department of Neurological Science, Graduate School of Medicine, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikako","family":"Nito","sequence":"additional","affiliation":[{"name":"Department of Neurological Science, Graduate School of Medicine, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Nishiyama","sequence":"additional","affiliation":[{"name":"Department of Neurological Science, Graduate School of Medicine, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Suda","sequence":"additional","affiliation":[{"name":"Department of Neurological Science, Graduate School of Medicine, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Neurological Science, Graduate School of Medicine, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Aoki","sequence":"additional","affiliation":[{"name":"Department of Neurological Science, Graduate School of Medicine, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Shimoyama","sequence":"additional","affiliation":[{"name":"Department of Neurological Science, Graduate School of Medicine, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Kanamaru","sequence":"additional","affiliation":[{"name":"Department of Neurological Science, Graduate School of Medicine, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Neurological Science, Graduate School of Medicine, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Neurological Science, Graduate School of Medicine, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Mishina","sequence":"additional","affiliation":[{"name":"Department of Neuro-pathophysiological Imaging, Graduate School of Medicine, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Neurological Science, Graduate School of Medicine, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Sacco S, Marini C, Toni D, Olivieri L, Carolei A. Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry. <i>Stroke<\/i> 2009; 40: 394\u2013399.","DOI":"10.1161\/STROKEAHA.108.523209"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Schulman S. Resumption of oral anticoagulation after warfarin-associated intracerebral hemorrhage: No. <i>Stroke<\/i> 2011; 42: 3663\u20133664.","DOI":"10.1161\/STROKEAHA.111.621813"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Steiner T. Resumption of oral anticoagulation after warfarin-associated intracerebral hemorrhage: Yes. <i>Stroke<\/i> 2011; 42: 3661\u20133662.","DOI":"10.1161\/STROKEAHA.111.621797"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Gregory PC, Kuhlemeier KV. Prevalence of venous thromboembolism in acute hemorrhagic and thromboembolic stroke. <i>Am J Phys Med Rehabil<\/i> 2003; 82: 364\u2013369.","DOI":"10.1097\/01.PHM.0000064725.62897.A5"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Poli D, Antonucci E, Dentali F, Erba N, Testa S, Tiraferri E, et al. Recurrence of ICH after resumption of anticoagulation with VK antagonists: CHIRONE study. <i>Neurology<\/i> 2014; 82: 1020\u20131026.","DOI":"10.1212\/WNL.0000000000000245"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kuramatsu JB, Gerner ST, Schellinger PD, Glahn J, Endres M, Sobesky J, et al. Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. <i>JAMA<\/i> 2015; 313: 824\u2013836.","DOI":"10.1001\/jama.2015.0846"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Murthy SB, Gupta A, Merkler AE, Navi BB, Mandava P, Iadecola C, et al. Restarting anticoagulant therapy after intracranial hemorrhage: A systematic review and meta-analysis. <i>Stroke<\/i> 2017; 48: 1594\u20131600.","DOI":"10.1161\/STROKEAHA.116.016327"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Nielsen PB, Larsen TB, Skjoth F, Gorst-Rasmussen A, Rasmussen LH, Lip GY. Restarting anticoagulant treatment after intracranial hemorrhage in patients with atrial fibrillation and the impact on recurrent stroke, mortality, and bleeding: A nationwide cohort study. <i>Circulation<\/i> 2015; 132: 517\u2013525.","DOI":"10.1161\/CIRCULATIONAHA.115.015735"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ottosen TP, Grijota M, Hansen ML, Brandes A, Damgaard D, Husted SE, et al. Use of antithrombotic therapy and long-term clinical outcome among patients surviving intracerebral hemorrhage. <i>Stroke<\/i> 2016; 47: 1837\u20131843.","DOI":"10.1161\/STROKEAHA.116.012945"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Witt DM, Clark NP, Martinez K, Schroeder A, Garcia D, Crowther MA, et al. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage. <i>Thromb Res<\/i> 2015; 136: 1040\u20131044.","DOI":"10.1016\/j.thromres.2015.10.002"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Barco S, Klok FA, Dentali F. Letter by Barco et al. Regarding article, \u201cRestarting anticoagulant therapy after intracranial hemorrhage: A systematic review and meta-analysis\u201d. <i>Stroke<\/i> 2017; 48: e266.","DOI":"10.1161\/STROKEAHA.117.018509"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. <i>N Engl J Med<\/i> 2009; 361: 1139\u20131151.","DOI":"10.1056\/NEJMoa0905561"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, et al. Edoxaban versus warfarin in patients with atrial fibrillation. <i>N Engl J Med<\/i> 2013; 369: 2093\u20132104.","DOI":"10.1056\/NEJMoa1310907"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, et al. Apixaban versus warfarin in patients with atrial fibrillation. <i>N Engl J Med<\/i> 2011; 365: 981\u2013992.","DOI":"10.1056\/NEJMoa1107039"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. <i>N Engl J Med<\/i> 2011; 365: 883\u2013891.","DOI":"10.1056\/NEJMoa1009638"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, et al. Oral apixaban for the treatment of acute venous thromboembolism. <i>N Engl J Med<\/i> 2013; 369: 799\u2013808.","DOI":"10.1056\/NEJMoa1302507"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Schulman S, Kakkar AK, Goldhaber SZ, Schellong S, Eriksson H, Mismetti P, et al. Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis. <i>Circulation<\/i> 2014; 129: 764\u2013772.","DOI":"10.1161\/CIRCULATIONAHA.113.004450"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). <i>Eur Heart J<\/i> 2010; 31: 2369\u20132429.","DOI":"10.1093\/eurheartj\/ehq278"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Gregoire SM, Chaudhary UJ, Brown MM, Yousry TA, Kallis C, Jager HR, et al. The Microbleed Anatomical Rating Scale (MARS): Reliability of a tool to map brain microbleeds. <i>Neurology<\/i> 2009; 73: 1759\u20131766.","DOI":"10.1212\/WNL.0b013e3181c34a7d"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Linn J, Halpin A, Demaerel P, Ruhland J, Giese AD, Dichgans M, et al. Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. <i>Neurology<\/i> 2010; 74: 1346\u20131350.","DOI":"10.1212\/WNL.0b013e3181dad605"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Shinohara Y. For readers (stroke specialists and general practitioners) of the Japanese guidelines for the management of stroke: Preface. <i>J Stroke Cerebrovasc Dis<\/i> 2011; 20: S1\u2013S6.","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.05.002"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Maeda K, Koga M, Okada Y, Kimura K, Yamagami H, Okuda S, et al. Nationwide survey of neuro-specialists\u2019 opinions on anticoagulant therapy after intracerebral hemorrhage in patients with atrial fibrillation. <i>J Neurol Sci<\/i> 2012; 312: 82\u201385.","DOI":"10.1016\/j.jns.2011.08.017"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Osaki M, Koga M, Maeda K, Hasegawa Y, Nakagawara J, Furui E, et al. A multicenter, prospective, observational study of warfarin-associated intracerebral hemorrhage: The SAMURAI-WAICH study. <i>J Neurol Sci<\/i> 2015; 359: 72\u201377.","DOI":"10.1016\/j.jns.2015.10.031"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. van Nieuwenhuizen KM, van der Worp HB, Algra A, Kappelle LJ, Rinkel GJ, van Gelder IC, et al. Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): Study protocol for a randomised controlled trial. <i>Trials<\/i> 2015; 16: 393.","DOI":"10.1186\/s13063-015-0898-4"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/83\/2\/83_CJ-18-0938\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T22:35:00Z","timestamp":1573598100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/83\/2\/83_CJ-18-0938\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,25]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-18-0938","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,25]]}}}